tiprankstipranks
Aldeyra Therapeutics (ALDX)
NASDAQ:ALDX
US Market
ALDX
Aldeyra Therapeutics
RESEARCH TOOLSreports
Want to see ALDX full AI Analyst Report?

Aldeyra Therapeutics (ALDX) Financial Statements

1,735 Followers

Aldeyra Therapeutics Financial Overview

Aldeyra Therapeutics's market cap is currently $101.34M. The company's EPS TTM is $-0.4572; its P/E ratio is -7.38; Aldeyra Therapeutics is scheduled to report earnings on April 30, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -35.27M$ -60.12M$ -42.79M$ -62.68M$ -56.22M
EBITDA$ -31.69M$ -53.68M$ -35.21M$ -60.07M$ -55.77M
Net Income$ -33.85M$ -55.85M$ -37.54M$ -62.02M$ -57.78M
Balance Sheet
Cash & Short-Term Investments$ 70.04M$ 101.15M$ 142.82M$ 174.30M$ 229.79M
Total Assets$ 72.06M$ 104.61M$ 148.33M$ 181.29M$ 233.14M
Total Debt$ 15.53M$ 15.30M$ 15.66M$ 16.08M$ 15.86M
Net Debt$ -54.51M$ -39.22M$ -127.17M$ -128.34M$ -213.93M
Total Liabilities$ 27.81M$ 33.60M$ 28.53M$ 30.28M$ 27.40M
Stockholders' Equity$ 44.25M$ 71.00M$ 119.80M$ 151.01M$ 205.74M
Cash Flow
Free Cash Flow$ -33.35T$ -43.21M$ -30.33M$ -56.65M$ -42.56M
Operating Cash Flow$ -33.35T$ -43.21M$ -30.33M$ -56.64M$ -42.56M
Investing Cash Flow$ 47.74T$ -44.92M$ 30.00M$ -29.95M$ -7.81K
Financing Cash Flow$ 1.12T$ -171.42K$ -1.27M$ 1.22M$ 194.50M
Currency in USD

Aldeyra Therapeutics Earnings and Revenue History

Income Statement >

Aldeyra Therapeutics Debt to Assets

Balance Sheet >

Aldeyra Therapeutics Cash Flow

Cash Flow >

Aldeyra Therapeutics Forecast EPS vs Actual EPS

Earnings >